Changes in serum tryptophan catabolism as an indicator of disease activity in adult T-cell leukemia/lymphoma

Leuk Lymphoma. 2009 Aug;50(8):1372-4. doi: 10.1080/10428190903045393.
No abstract available

Publication types

  • Letter

MeSH terms

  • Aged
  • Antineoplastic Combined Chemotherapy Protocols / administration & dosage
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Carboplatin / administration & dosage
  • Cyclophosphamide / administration & dosage
  • Doxorubicin / administration & dosage
  • Drug Monitoring
  • Etoposide / administration & dosage
  • Female
  • Granulocyte Colony-Stimulating Factor / therapeutic use
  • Humans
  • Indoleamine-Pyrrole 2,3,-Dioxygenase / metabolism
  • Kynurenine / blood
  • Leukemia-Lymphoma, Adult T-Cell / blood*
  • Leukemia-Lymphoma, Adult T-Cell / drug therapy
  • Leukemia-Lymphoma, Adult T-Cell / enzymology
  • Metabolic Networks and Pathways
  • Neoplasm Proteins / metabolism
  • Neoplastic Cells, Circulating
  • Neutropenia / chemically induced
  • Neutropenia / drug therapy
  • Nitrosourea Compounds / administration & dosage
  • Prednisone / administration & dosage
  • Receptors, Interleukin-2 / blood
  • Tryptophan / blood*
  • Tryptophan Oxygenase / metabolism
  • Vincristine / administration & dosage
  • Vindesine / administration & dosage

Substances

  • Indoleamine-Pyrrole 2,3,-Dioxygenase
  • Neoplasm Proteins
  • Nitrosourea Compounds
  • Receptors, Interleukin-2
  • Granulocyte Colony-Stimulating Factor
  • Kynurenine
  • Vincristine
  • Etoposide
  • Doxorubicin
  • Tryptophan
  • Cyclophosphamide
  • Carboplatin
  • Tryptophan Oxygenase
  • Vindesine
  • ranimustine
  • Prednisone

Supplementary concepts

  • CHOP protocol